Skip to main content

Eli Lilly to offer half-priced versions of two more insulin products

By Reuters  
   January 15, 2020

Eli Lilly and Co said on Tuesday it plans to sell two versions of insulin products at half their current U.S. list prices, eight months after it started selling a half-priced version of its widely-used Humalog injection.

Full story

Get the latest on healthcare leadership in your inbox.